Properties and use of botulinum toxin and other microbial neurotoxins in medicine.
Crystalline botulinum toxin type A was licensed in December 1989 by the Food and Drug Administration for treatment of certain spasmodic muscle disorders following 10 or more years of experimental treatment on human volunteers. Botulinum toxin exerts its action on a muscle indirectly by blocking the...
Salvato in:
| Pubblicato in: | Microbiol Rev |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1992
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC372855/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1579114/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mr.56.1.80-99.1992 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|